Patients with prehypertension who take blood pressure—lowering therapy have a highly statistically significant 22% reduced risk for stroke, a new meta-analysis shows.
The reduction in stroke risk observed in the study was "clear-cut," "clinically meaningful," and evident among all classes of antihypertensive drugs studied, said lead author Ilke Sipahi, MD, assistant professor of medicine, Case Western Reserve University, Cleveland, Ohio, and associate director, Heart Failure and Transplantation at University Hospitals Case Medical Center.
"We saw it with [angiotensin converting enzyme (ACE)] inhibitors, we saw it with calcium channel blockers, and we saw it with angiotensive-receptor blockers [ARBs] to a certain extent," Dr. Sipahi told Medscape Medical News. "So this is true finding: the risk is truly reduced."
However, the study results should not change current recommendations regarding blood pressure—lowering therapy, said Dr. Sipahi. "It's not realistic to go ahead and recommend antihypertensive therapy to every single patient with prehypertensive blood pressure levels, but I think our findings have to be discussed extensively within the medical community.
The study was published online December 8 in Stroke, the Journal of the American Heart Association.
Read more at: http://www.medscape.com/viewarticle/755077?sssdmh=dm1.741070&src=nldne
Source: Medscape Medical News
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More